Research and Markets Adds Report: China Hospital Development and Investment Report,-2017

Research and Markets has announced the addition of the "China Hospital Development and Investment Report,-2017" report to its offerings.

In a release, Research and Markets noted that report highlights include:

China hospital industry has been developing quickly in recent years, thanks to the market demand stimulus and steady progress in health care reform. The number of Chinese hospitals grew at a CAGR of 6 percent in 2011-2013, higher than 2.26 percent in 2005-2010. The revenue of China hospital industry jumped at a CAGR of 23.6 percent in 2011-2013, and it is expected to maintain the growth rate of over 20 percent and hit RMB4.07 trillion in 2017.

At the same time, various social capital flows to the Chinese hospital market by self-establishment, mergers and acquisitions (including participation in the restructuring of public hospitals), joint ventures, associates and other forms, which boosts the expansion of private hospitals. As of the end of 2013, Chinese private hospitals had accounted for 45.8 percent of the total Chinese hospitals, increasing by 24.5 percentage points compared with 2006. However, from the point of view of revenue structure, public hospitals still took a dominant position with the proportion of over 90 percent, but the figure shows a decreasing trend now.

Companies Mentioned:

-Aier Eye Hospital Group

-CMS Holdings Ltd.

-China Resources Sanjiu

-Inner Mongolia Furui Medical Science

-Jiangnan Mould & Plastic Technology

-Jinling Pharmaceutical

-Kangmei Pharmaceutical

-Mayinglong Pharm

-Parkway Pantai

-Phoenix Healthcare

-Shanghai Fosun Pharmaceutical

-Shinva Medical

-TC Medical

-United Family Hospital

-Wuhan Jianmin Pharmaceutical

-Xi'an Kaiyuan Investment

-Yibai Pharmaceutical

Report information:

http://www.researchandmarkets.com/research/89xvp7/china_hospital

((Comments on this story may be sent to [email protected]))